title: [Multivariate analysis on virologic breakthrough in HBeAg  positive patients treated with lamivudine].
authors.affiliation: Xiamen Hospital of TraditionalXiamen Hospital of Traditional Chinese Medicine, Xiamen 361009, China. yujing_tang@tom.com
authors.forename: Yu-jing
authors.initials: YJ
authors.lastname: Tang
authors.forename: Yu-qian
authors.initials: YQ
authors.lastname: Hong
authors.forename: Li-juan
authors.initials: LJ
authors.lastname: Ouyang
authors.forename: Qing-fa
authors.initials: QF
authors.lastname: Ruan
authors.forename: Hong-tao
authors.initials: HT
authors.lastname: Yu
authors.forename: Jun-fang
authors.initials: JF
authors.lastname: Zhao
authors.forename: Qian-guo
authors.initials: QG
authors.lastname: Mao
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral; D005260:Female; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D044966:Anti-Retroviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D019259:Lamivudine